glp 1 drugs for sleep apnea Comparing Ozempic, Wegovy and Other GLP-1 Indications for GLP-1/GIP RA Summary
Description
DPP4 is the enzyme that breaks down GLP-1, so by inhibiting DPP4, GLP-1 may hang around in the system longer

GLP-1 (Glucagon-like peptide-1) is an incretin secreted from intestinal L cells

In recent years, we have witnessed a paradigm shift in cardiometabolic medicine: The SELECT trial demonstrated that GLP-1 receptor agonists reduce cardiovascular events even in patients without diabetes
For example, cardiovascular outcomes trials have already shown that GLP-1 drugs reduce major heart events in people with diabetes and obesity

Improvements were also noted in fasting insulin and insulin resistance (HOMA-IR), although no significant differences in glucose levels were observed [42]

UK Prospective Diabetes Study (UKPDS) Group
)